Company: SXTPW
Filing Date: 2025-01-30
Form Type: 424B5
Source: 0001213900-25-008098
Chunk: 36

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-01-30
Form: 424B5
Chunk 36
---
725 per share;                                                                         |

| ● | shares                                                                                     
 of common stock issuable upon the conversion of 76,480 shares of Series A Preferred Stock; |

| ● | 1,666,670                                                                                 
 shares of common stock issuable upon the exercise of the Private Placement Warrants to be 
 issued in the concurrent private placement at an exercise price of $0.771 per share; and  |

| ● | 76,616                                                                                     
 shares of common stock issuable upon the exercise of placement agent warrants to be issued 
 as compensation to the placement agent (or its designee) in connection with this offering  
 at an exercise price of $1.2763 per share.                                                 |

<div align='center'>S-22

DESCRIPTION OF SECURITIES</div>

Description of the Common Stock

A description of the common stock we are offering pursuant to this prospectus supplement is set forth under the heading “ Description of Capital Stock – Common Stock,” starting on page 21 of the accompanying prospectus. As of January 28, 2025, we had 4,395,505 shares of common stock outstanding.

<div align='center'>S-23

PLAN OF DISTRIBUTION</div>

Pursuant to an engagement letter agreement between and H.C. Wainwright dated August 30, 2024, as amended on September 3, 2024 and January 24, 2025 (the “Engagement Agreement”), we have engaged H.C. Wainwright to act as our exclusive Placement Agent to solicit offers to purchase the shares of common stock offered by this prospectus supplement and accompanying prospectus. The Placement Agent is not purchasing or selling any securities, nor is it required to arrange for the purchase and sale of any specific number or dollar amount of securities, other than to use its reasonable “best efforts” to arrange for the sale of all of the securities offered hereby. We have entered into securities purchase agreement directly with the investors in connection with this offering for the sale of all of the shares of common stock offered hereby (and the issuance of the Private Placement Warrants, which are not being offered herein, but are being issued in a separate concurrent offering, exempt from registration under the Securities Act). We will only sell to such investors who have entered into the securities purchase agreement with us.

The Engagement Agreement provides that the Placement Agent’s obligations are subject to conditions contained in the Engagement Agreement.

We will deliver the securities being issued to the investors upon receipt of investor funds for the purchase of the securities